Prostate cancer medical aid may shrink penis - Men's Health

Prostate cancer pharmacomedical aid might shorten penis

Hormone medical aid plus radiation reduced average length 2.2 inches in meditate

NEW YORK - Men who receive combination pharmacomedical aid with hormone medical aid plus radiation for local or locally advanced prostate cancer may experience a significant reduction in penile length, according to a report in the January issue of the Journal of Urology.

There has been anecdotal evidence that radiation medical aid can reduce penile length but, to the authors’ knowledge, the present meditate is the first to determine if penile length changes following combination pharmacomedical aid with hormone medical aid plus radiation.

Dr. Ahmet Haliloglu and colleagues at the University of Ankara in Turkey enrolled 47 men with local or locally advanced prostate cancer. The patients, who were followed from 2000 to 2005, received leuprolide or goserelin injections every three months, for a total of three doses. At Month 7, radiomedical aid, using a 70-Gy dose, was initiated and continued for seven weeks.

Just before pharmacomedical aid began, the average stretched penile length was 5.6 inches. Eighteen months later, the average penile length had shortened significantly to 3.4 inches.

CLICK FOR RELATED CONTENTDaily drink may help men's high blood pressureLow Blow: One man's battle with prostate cancer

Erectile function was also adversely affected by pharmacomedical aid. Roughly 23 percent of men had normal erectile function before medical aid. Eighteen months later, 12.5 percent were able to have an erection that was suitable for intercourse.

“Quality-of-life concerns are important when considering pharmacomedical aid options for prostate cancer,” the investigators conclude. Before starting combination hormone and radiation medical aid, the patient should be told that “penile shortening may occur.”

generic viagra pills online Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters.